Rob Lown

A new trial to improve treatment for severe lupus is being led by @uclh colleagues. Using CAR-T therapy to modify the immune system to target unhealthy cells, the trial could reduce, or even remove, the need for lifelong medication for severe lupus. uclh.nhs.uk/news/uclh-anno…

@tobyeyre82 Must be your yacht in the foreground Toby.

So promising..& privilege to lead in 🇬🇧 & 🇪🇸 ‘TRBC1-CAR T cell therapy in PTCL: a phase 1/2 trial’ Co-I @gloria_iacoboni #ETholouli @tobiasmenne2 #DIrvine Huge science credit to #MartinPule @paulmaciocia #MatFerrari #TeresaMarafioti et al #Autolus @NatureMedicine @uclcancer

📺 In the spotlight: Allan's remarkable recovery with CAR T-cell therapy at UHS. 🏥 This week, former Royal bodyguard, Allan Peters' inspiring journey from 'terminal' cancer to full remission has been making headlines in local media and on national TV. 🧵(1/3) 👇

Not me btw…

Strava gives a nice example of why ‘I can still do a round of golf’ is a good marker of fitness. 4.5hrs on one’s feet over 10k distance is no mean feat!

A woman from Hampshire who was diagnosed with cancer and spent weeks in a coma while pregnant has celebrated the birth of her daughter. itv.com/news/meridian/…

An incredible story. 👇 Beth faced a diagnosis of Hodgkin Lymphoma complicated by encephalopathy causing her to be unconscious for the first few months of pregnancy. Last week, Beth visited our @UHS_lymphoma service with the lovely Isabella. 💕🌟 🔗 bbc.co.uk/news/articles/…

@BethanyMMaynard Great to see you both there - very well deserved!!

I’m extremely excited to be running the London Marathon next year for a charity close to my heart - Lymphoma Action. I would be grateful if you could spare 5 minutes to clink on this link and read more about the amazing charity and why it’s important to me justgiving.com/page/polly-pat…

(2/2) Picture shared with Beth's consent #teamwork #hero #miraclebaby #ourhero @UHSFT

Bit stiff

@tobyeyre82 Wish I could ‘double like’ this!

only 1 year to go until Lugano 2025 😀 #ICML25

Obe-cel (AUTO1), a CD19/41BB CAR-T cell therapy, shows fantastic results in relapsed/refractory B-cell acute lymphoblastic leukemia (B-ALL) in the Phase II FELIX trial. #CART WELL DONE @drclaireroddie and team ascopubs.org/doi/abs/10.120…

@graham74GC This is such a good study.

Great to see the escBEACOPDac data on MedRxiv. Procarbazine is genotoxic - much less so with dacarbazine and clinical outcomes similar. So until BreCADD funded, it's escBEACOPDac when intensive chemo needed in Hodgkin. medrxiv.org/content/10.110…

This is such a powerful regimen. 94% 4y PFS is incredible. In places thay use escBEACOPP (& which fund it) this will be the new standard. The question is how far it will extend into ABVD / AVD-N using areas. US colleagues - will you use it do you think?

Just love it. In the immortal words of Shaggy - it wasn’t me!

Good job Saints!

@graham74GC Hi Graham. Are we also expecting an update from SWOG1826 do you think?

EscBEACOPP vs BreCADD - HD21. Embargoed abstract but title says it all. Looks like efficacy is superior. #EHA24 #lymsm